Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The STEP-HFpEF trial showed that among patients with obesity and HFpEF, once-weekly semaglutide may be beneficial in terms of weight loss and quality of life
Side effects, tolerance, and safety considerations Cleveland Clinic reviews and other clinical guidance point out that the most common GLP-1 side effects are gastrointestinal: reduced appetite, nausea, vomiting, diarrhea, constipation, indigestion, and occasional dizziness or headache
1,188 GLP-1 reduces hepatic glucose production, partly by inhibiting the expression and activity of key gluconeogenic enzymes
Obese for sure you qualify, but also taking into consideration any comorbidities that you have like high cholesterol, high blood pressure, sleep apnea, PCOS. Given that more than 40% of American adults meet the clinical definition of obesity, a lot of people asking whether they qualify already do
A 2024 randomized controlled trial by Hansen et al
